Deals Rumor Mill: Suntory, America Movil, TDR Capital

Law360, New York (September 5, 2013, 3:52 PM EDT) -- Suntory Holdings Ltd. is closing in on a deal that would see it pay $1.6 billion for a pair of popular British drink brands from GlaxoSmithKline PLC, sources told Reuters on Thursday. A sale agreement would rule out an auction of the Lucozade and Ribena names, which have been on the selling block since April. Several private equity firms have been mentioned as contenders in the hunt for a buyer, but GSK has settled on Japan-based Suntory to safeguard the future of the brands, both top...
To view the full article, register now.